AAAAAA
Results:
1-13
|
Results: 13
Authors:
Kristoferitsch, W
Seeldrayers, P
Kyriallis, K
Brochet, B
Confavreux, C
Clanet, M
Cesaro, P
Defer, G
Edan, G
Lyon-Caen, O
Pelletier, J
Rumbach, L
Roullet, E
Vermersch, P
Dengler, R
Zschenderlein, R
Storch-Hagenlocher, B
Sailer, M
Hohlfeld, R
Kunze, KP
Heesen, C
Bamborschke, P
Grunwald, F
Hartung, HP
Rieckmann, P
DeKeyser, J
Montalban, X
Fernandez, U
Arbizu, T
Sandberg, M
Kappos, L
Bates, D
Campbell, MJ
Capildeo, R
Compston, A
McLellan, DL
Wroe, S
Young, C
Clanet, M
Hartung, HP
Hohlfeld, R
Kappos, L
Radue, EW
Rieckmann, P
Sandberg, M
Polman, C
Kesselring, J
Thompson, A
Wekerle, H
Whitehead, J
Bains, H
Butler, E
Kooijmans-Coutinho, M
McAllister, A
Simonian, N
White, K
Anderson, D
Liddiard, S
Keane, R
Citation: W. Kristoferitsch et al., Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data, MULT SCLER, 7(3), 2001, pp. 179-183
Authors:
McDonald, WI
Compston, A
Edan, G
Goodkin, D
Hartung, HP
Lublin, FD
McFarland, HF
Paty, DW
Polman, CH
Reingold, SC
Sandberg-Wollheim, M
Sibley, W
Thompson, A
van den Noort, S
Weinshenker, BY
Wolinsky, JS
Citation: Wi. Mcdonald et al., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, ANN NEUROL, 50(1), 2001, pp. 121-127
Authors:
Comi, G
Filippi, M
Barkhof, F
Durelli, L
Edan, G
Fernandez, O
Hartung, HP
Seeldrayers, P
Sorensen, PS
Rovaris, M
Martinelli, V
Hommes, OR
Citation: G. Comi et al., Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study, LANCET, 357(9268), 2001, pp. 1576-1582
Authors:
Edan, G
Citation: G. Edan, Treatment of rapidly worsening multiple sclerosis, REV NEUROL, 157(8-9), 2001, pp. 1008-1013
Authors:
Biraben, A
Allain, H
Scarabin, JM
Schuck, S
Edan, G
Citation: A. Biraben et al., Exacerbation of juvenile myoclonic epilepsy with lamotrigine - Reply from the authors, NEUROLOGY, 56(10), 2001, pp. 1424-1425
Authors:
Blumhardt, LD
Vermeij, BJD
Amato, M
Andersen, O
Edan, G
Fernandez, O
Filippi, M
Haas, J
Hommes, OR
Rieckmann, P
Citation: Ld. Blumhardt et al., A quality network model for the dolly care of multiple sclerosis, MULT SCLER, 6(4), 2000, pp. 231-236
Authors:
Edan, G
Coustans, M
Citation: G. Edan et M. Coustans, Does immunosuppression constitute a future therapeutic strategy in the treatment of multiple sclerosis?, PATH BIOL, 48(2), 2000, pp. 114-120
Authors:
de Seze, J
Edan, G
Labalette, M
Dessaint, JP
Vermersch, P
Citation: J. De Seze et al., Effect of glatiramer acetate (Copaxone) given orally in human patients: Interleukin-10 production during a phase 1 trial, ANN NEUROL, 47(5), 2000, pp. 686-686
Authors:
Reboul, J
Mertens, C
Levillayer, F
Eichenbaum-Voline, S
Vilkoren, T
Cournu, I
Babron, MC
Lyon-Caen, O
Clerget-Darpoux, F
Edan, G
Clanet, M
Brahic, M
Bureau, JF
Fontaine, B
Liblau, R
Citation: J. Reboul et al., Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach, J NEUROIMM, 102(1), 2000, pp. 107-112
Authors:
Drapier, S
Kassiotis, P
Mourtada, I
Pinel, JF
Edan, G
Citation: S. Drapier et al., Multiple strokes with livedo after anti-cancer therapy with Interleukin-2 and Interferon alpha, REV NEUROL, 156(10), 2000, pp. 901-903
Authors:
Biraben, A
Allain, H
Scarabin, JM
Schuck, S
Edan, G
Citation: A. Biraben et al., Exacerbation of juvenile myoclonic epilepsy with lamotrigine, NEUROLOGY, 55(11), 2000, pp. 1758-1758
Authors:
Brassat, D
Azais-Vuillemin, C
Yaouanq, J
Semana, G
Reboul, J
Cournu, I
Mertens, C
Edan, G
Lyon-Caen, O
Clanet, C
Fontaine, B
Citation: D. Brassat et al., Familial factors influence disability in MS multiplex families, NEUROLOGY, 52(8), 1999, pp. 1632-1636
Authors:
Edan, G
Citation: G. Edan, New therapeutic strategies for multiple sclerosis: unanswered questions, REV NEUROL, 154(12), 1998, pp. 813-815
Risultati:
1-13
|